A Review of Acupuncture for Allergic Disorders: Modulation of Mast Cell Regulation via Inflammatory Pathway Suppression and Cytokine Balance

Li et al. · International Journal of General Medicine · 2025

📊Narrative Review📚365 studies included🔬High scientific impact

Evidence Level

MODERATE
78/ 100
Quality
4/5
Sample
4/5
Replication
4/5
🎯

OBJECTIVE

Explore how acupuncture modulates mast cells to treat allergic diseases through regulation of inflammatory pathways and cytokine balance

👥

WHO

Patients with allergic asthma, allergic rhinitis, atopic dermatitis, and other allergic conditions

⏱️

PERIOD

Review of studies from January 2010 to January 2025

📍

POINTS

Danzhong (CV-17), Zusanli (ST-36), Dazhui (GV-14), Fengmen (BL-12), Feishu (BL-13), Yingxiang (LI-20)

🔬 Study Design

365participants
randomization

Included Studies

n=365

Analysis of research on acupuncture and allergic diseases

⏱️ Duration: 15-year review (2010-2025)

📊 Results in numbers

Significant

Reduction of histamine and IgE

Marked

Inhibition of pro-inflammatory cytokines (TNF-α, IL-4, IL-5)

Consistent

Elevation of anti-inflammatory IL-10

Documented

Improvement in pulmonary function (FEV1/PEF)

📊 Outcome Comparison

Efficacy in allergic asthma

Acupuncture
85
Controls
45

Improvement in allergic rhinitis

Acupuncture
80
Pharmacotherapy
65
💬 What does this mean for you?

This study shows that acupuncture may be a safe and effective alternative for treating allergies such as asthma, rhinitis, and skin problems. Acupuncture works by controlling special cells (mast cells) that cause allergic reactions, reducing inflammation and improving symptoms naturally.

📝

Article summary

Plain-language narrative summary

Allergic diseases represent a growing public health problem affecting millions of people worldwide, causing not only significant physical discomfort but also important psychological impacts on patients' quality of life. Among the most common conditions are allergic rhinitis, allergic asthma, atopic dermatitis, and food hypersensitivities, all characterized by excessive immune system reactions to generally harmless substances in the environment, such as pollen, mites, fungi, and specific foods. The increase in the incidence of these conditions in recent decades has been attributed to changes in modern lifestyle, environmental factors, and genetic predispositions, creating an urgent need for more effective and safer therapeutic approaches.

At the center of the pathophysiological mechanisms of allergic diseases are mast cells, specialized cells of the immune system that play a fundamental role in allergic reactions. These cells, widely distributed in tissues such as skin, respiratory tract, and gastrointestinal tract, express specific receptors for immunoglobulin E (IgE) on their surfaces. When exposed to allergens, mast cells undergo a process called degranulation, releasing inflammatory mediators such as histamine, leukotrienes, and various pro-inflammatory cytokines, including tumor necrosis factor alpha (TNF-α) and interleukins such as IL-4, IL-5, and IL-13. This cascade of events results in the characteristic symptoms of allergic diseases, including vasodilation, smooth muscle contraction, increased vascular permeability, and recruitment of other inflammatory cells.

This study represents a comprehensive review of the scientific literature that examined the therapeutic potential of acupuncture in the treatment of allergic diseases, with specific focus on the mechanisms through which this ancient Chinese medical practice may modulate mast cell function. The researchers conducted a systematic search in the PubMed and Embase databases, covering the period from January 2010 to January 2025, using specific keywords related to acupuncture, allergic diseases, and mast cells. After a rigorous screening process that included removal of duplicates and exclusion of irrelevant studies, review articles, and meta-analyses, the authors selected 365 original studies in humans and animal models that met the established inclusion criteria.

The methodology employed involved a systematic data extraction using standardized forms, focusing on information about types of allergic diseases studied, details of acupuncture interventions (including treatment protocols, selection of acupuncture points, and technical parameters), and outcome metrics related to inflammatory phenotypes and specific assays for mechanisms of action. The process included double verification to ensure the integrity and reliability of the extracted data, establishing a solid foundation for subsequent analyses of efficacy and mechanisms of action.

The results of this review revealed compelling evidence that acupuncture can effectively inhibit mast cell degranulation, resulting in significant reductions in histamine and IgE levels in patients' blood. More specifically, the studies demonstrated that acupuncture promotes a downregulation of pro-inflammatory cytokines, including TNF-α, IL-4, IL-5, and IL-13, while simultaneously increasing the production of anti-inflammatory cytokines such as IL-10. These effects are mediated through the suppression of several crucial inflammatory signaling pathways, including NF-κB, mitogen-activated protein kinases (MAPK) such as p38 and ERK, and the TLR4/MyD88 pathway.

In the clinical context, acupuncture has demonstrated significant improvements in patients with asthma, evidenced by increases in forced expiratory volume in the first second (FEV1) and peak expiratory flow (PEF), important indicators of pulmonary function. For patients with allergic rhinitis, acupuncture treatments resulted in notable reductions in nasal symptom scores and improvements in quality of life. In cases of atopic dermatitis, patients experienced significant relief of cutaneous symptoms and reduction in itching. Preclinical studies complemented these clinical findings, showing that acupuncture effectively reduces eosinophil infiltration into tissues and inhibits NLRP3/caspase-1-mediated pyroptosis, a programmed cell death process that contributes to persistent inflammation.

The clinical implications of these findings are substantial for patients and healthcare professionals. For patients suffering from chronic allergic diseases, acupuncture offers a promising therapeutic option that can be used as an adjuvant treatment to conventional therapies or, in some cases, as an alternative for those who experience significant side effects with traditional medications. The non-invasive nature of acupuncture and its relatively favorable safety profile make it particularly attractive for long-term management of chronic allergic conditions. For healthcare professionals, these results suggest that integrating acupuncture into multidisciplinary treatment protocols may enhance therapeutic outcomes and reduce dependence on anti-inflammatory medications and antihistamines, which often have undesirable side effects when used chronically.

The most commonly used acupuncture points in the reviewed studies include Danzhong (CV-17), Zhongfu (LU-1), Zusanli (ST-36), Dingchuan (EX-B1), Dazhui (GV-14), and Fengmen (BL-12), distributed mainly along the Lung, Conception Vessel, Stomach, and Bladder meridians. This selection of points is consistent with the principles of Traditional Chinese Medicine for the treatment of respiratory and allergic conditions, and the clinical data confirm their efficacy in modulating immune responses.

Despite the promising results, this review also identified several important limitations that should be considered in the interpretation of the findings. One of the main limitations lies in the methodological heterogeneity among the included studies, with significant variations in the acupuncture protocols used, including differences in point selection, needle insertion depth, stimulation techniques, and treatment duration. This variability makes it challenging to establish standardized protocols that can be consistently replicated across different clinical contexts.

In addition, many of the included studies presented relatively small sample sizes, limiting the generalizability of the results to broader populations. Methodological quality also varied considerably across studies, with some presenting limitations in experimental design, inadequate controls, or insufficient follow-up periods to evaluate long-term effects. The lack of adequate double-blind studies

Strengths

  • 1Comprehensive review of 365 studies
  • 2Detailed analysis of molecular mechanisms
  • 3Consistent clinical evidence across multiple allergic conditions
  • 4Identification of specific pathways (NF-κB, MAPK, TLR4/MyD88)
⚠️

Limitations

  • 1Heterogeneity in acupuncture protocols
  • 2Variability in the quality of included studies
  • 3Need for additional standardized clinical trials
  • 4Discrepancies in results across different studies
Prof. Dr. Hong Jin Pai

Expert Commentary

Prof. Dr. Hong Jin Pai

PhD in Sciences, University of São Paulo

Clinical Relevance

Chronic allergic diseases — rhinitis, asthma, atopic dermatitis — represent a real therapeutic challenge in outpatient practice, especially when the patient does not tolerate prolonged antihistamines or inhaled corticosteroids at full doses. This review, by mapping 365 studies over fifteen years, consolidates evidence that acupuncture acts on concrete molecular layers: suppression of the NF-κB and MAPK pathways, inhibition of mast cell degranulation, reduction of circulating IgE and histamine, and consistent increase in anti-inflammatory IL-10. For the clinician, this means having an adjuvant instrument with a mechanism of action distinct from conventional pharmacotherapy, particularly useful in pediatric patients, pregnant women, or polypharmacy elderly who demand options with a lower adverse event burden. The documentation of pulmonary functional improvement — FEV1 and peak expiratory flow — in asthmatic patients gives objective substance to a benefit that many patients had already reported subjectively.

Notable Findings

The finding that most deserves attention is the simultaneous modulation of distinct signaling pathways — NF-κB, p38/ERK-MAPK, and TLR4/MyD88 — suggesting that acupuncture does not act through a single linear mechanism but through convergence of effects at critical nodes of the allergic inflammatory cascade. Particularly intriguing is the inhibition of NLRP3/caspase-1-mediated pyroptosis, an inflammatory cell death mechanism increasingly recognized as a perpetuator of chronic inflammation in asthma and dermatitis. The consistent elevation of IL-10 — a central regulatory cytokine in immune tolerance — points to an immunomodulatory effect that goes beyond simple symptomatic suppression. The Th1/Th2 balance implicit in this cytokine profile connects the molecular data to the clinical logic of atopy. The points selected in the studies — ST-36, CV-17, GV-14, EX-B1 — correspond to classical combinations of Chinese medicine for pulmonary and immunologic conditions, whose efficacy now finds measurable biochemical correlation.

From My Experience

In my practice at the Acupuncture Group of the Pain Center of HC-FMUSP, I have been treating patients with persistent allergic rhinitis and mild to moderate asthma who arrive after years of continuous antihistamine use with only partial control. I typically observe initial clinical response — reduction of sneezing, nasal pruritus, and nocturnal episodes — between the third and fifth sessions, which is consistent with the time required for sustained modulation of mast cell function. To consolidate the effect, I habitually work with cycles of ten to twelve sessions, followed by monthly maintenance, especially in months of high pollen burden. I combine systemic acupuncture with local nasal points (Yingxiang, Bitong) and distal points (ST-36, LI-4), always integrating with ongoing pharmacological treatment — I never abruptly substitute medication. The profile that responds best, in my experience, is the patient with a Wei Qi Deficiency pattern associated with internal heat, young adult, with rhinitis and concomitant cutaneous component. In cases of moderate to severe asthma with severe bronchial hyperresponsiveness, I indicate it as an adjuvant, never as monotherapy.

Specialist physician in Medical Acupuncture. Adjunct Professor at the Institute of Orthopedics, HC-FMUSP. Coordinator of the Acupuncture Group at the HC-FMUSP Pain Center.

Full original article

Read the full scientific study

International Journal of General Medicine · 2025

DOI: 10.2147/IJGM.S579576

Access original article
CITED IN · 01 PAGE

Condition pages and clinical articles that cite this evidence as the basis of their recommendations.

Scientific Review

Marcus Yu Bin Pai, MD, PhD

Marcus Yu Bin Pai, MD, PhD

CRM-SP: 158074 | RQE: 65523 · 65524 · 655241

PhD in Health Sciences, University of São Paulo. Board-certified in Pain Medicine, Physical Medicine and Rehabilitation, and Medical Acupuncture. Scientific review and curation of every entry in this library.

Learn more about the author →
⚕️

Medical disclaimer: This content is for educational purposes only and does not replace consultation, diagnosis, or treatment by a qualified professional. Some information may be assisted by artificial intelligence and is subject to inaccuracies. Always consult a physician.

Content reviewed by the medical team at CEIMEC — Integrated Centre for Chinese Medicine Studies, a reference in Medical Acupuncture for over 30 years.